Max Robotics — Global Service Robot Directory + US Certification

About

Liron Kogan is a leading voice in gynecologic oncology, whose research is reshaping how robotic surgery is integrated into cancer care. Her work centers on three critical areas: the clinical efficacy of robotic-assisted procedures, their economic and operational impact on healthcare systems, and the refinement of surgical techniques for ovarian and cervical cancers. Kogan’s landmark 2019 study on robotic surgery after neoadjuvant chemotherapy for ovarian cancer (43 citations) demonstrated that the approach is both safe and oncologically sound, challenging traditional open-surgery paradigms. She further advanced the field with a 2018 comparative analysis showing robotic radical hysterectomy offers comparable oncologic outcomes to open surgery for cervical cancer (31 citations), while a 2018 investigation into thromboembolic risks in endometrial cancer (24 citations) provided vital safety data. Beyond clinical outcomes, Kogan has pioneered health systems research, quantifying how robotic platforms streamline patient flow and reduce resource intensity—a perspective that bridges surgical innovation with hospital administration. Her 2020 paper on the shifting financial landscape of robotic interfaces (21 citations) remains a key reference for cost-conscious adoption. Through this three-pronged approach—clinical validation, safety profiling, and operational analysis—Kogan is helping to define the future of minimally invasive gynecologic oncology.